Dr. Meier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1560 N 115th Street Suite G16
Co Swedish Cancer Institute Northwest
Seattle, WA 98133Phone+1 206-386-6707Fax+1 206-363-5907
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 1986 - 1989
St Mary Medical CenterInternship, Internal Medicine, 1985 - 1986
David Geffen School of Medicine at UCLAClass of 1985
Certifications & Licensure
CA State Medical License 1987 - Present
WA State Medical License 1997 - 2025
OR State Medical License 2020 - 2022- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013
Clinical Trials
- CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution Start of enrollment: 2007 Dec 01
- Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer Start of enrollment: 2014 Dec 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 81 citationsMulticenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints.Robert M. Meier, Daniel A. Bloch, C. Cotrutz, Alan C. Beckman, G. Henning
International Journal of Radiation Oncology, Biology, Physics. 2018-10-01 - 3 citationsToxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series.Jesus E. Juarez, Tahmineh Romero, Constantine Mantz, Abigail Pepin, Nima Aghdam
Advances in Radiation Oncology. 2021-08-28
Press Mentions
Largest Prostate SBRT Studies to Date Show Accuray CyberKnife Provides Excellent Survival Rates in Five or Fewer SessionsSeptember 26th, 2018
SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer TreatmentsSeptember 26th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
